抗菌感应模式的比较 链球菌肺炎 呼吸道隔离物:系统性审查和元分析
Abdulhamit Cali1, Rukiye Aslan2, Cem Celik3
1Medical Laboratory Techniques, Vocational School of Health Services, Lokman Hekim University, Ankara, Turkey.
Tropical medicine & international health : TM & IH
|February 18, 2026
概括
肺炎链球菌的多种药物耐药性是一个日益严重的全球性问题. 这一审查揭示了抗生素易感性的显著区域差异,强调了需要量身定制的管理策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 肺炎链球菌 (Streptococcus pneumoniae) 是导致细菌性呼吸道感染的主要原因.
- 抗菌素耐药性 (AMR) 的增加威胁到有效的治疗选择.
- 全球对抗药物耐药性模式的监测对公共卫生至关重要.
研究的目的:
- 系统地审查和元分析S. pneumoniae的全球和区域抗菌素敏感性模式.
- 评估从2015年到2024年的S. pneumoniae耐药性的趋势.
- 为更新的治疗指南和管理策略提供信息.
主要方法:
- 在Scopus,PubMed和Web of Science (2015-2024) 的系统文献搜索.
- 包括英语语言研究的人类呼吸道隔离物中S. pneumoniae易感性的研究.
- 随机效应模型的元分析与WHO区域的子组分析.
主要成果:
- 分析了33项与20768个分离物的研究.
- 对线索利德 (100%) 和万科米辛 (99%) 的高度敏感性.
- 青素敏感性因地区而异 (例如,非洲61%,地中海东部26%).
- 西太平洋地区的红色素和四环素敏感性显著下降.
- 对于三甲胺-硫甲醇和克林达米辛观察到的区域变异性.
结论:
- S. pneumoniae呼吸道分离物的抗微生物敏感性显示出很大的区域差异.
- 降低敏感性和新出现的耐药性需要特定区域的抗生素管理.
- 更新的治疗指南对于对抗S. pneumoniae耐药性至关重要.
相关概念视频
Pneumonia III: Complications and Assessment
938
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
938
Pneumonia I: Introduction
953
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
953
Pneumonia IV: Management
839
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
839
Pneumonia II: Pathophysiology
3.3K
The pathophysiology of pneumonia involves the following steps:
3.3K


